Review of RM-1929 Near-Infrared Photoimmunotherapy Clinical Efficacy for Unresectable and/or Recurrent Head and Neck Squamous Cell Carcinoma

SIMPLE SUMMARY: RM-1929 near-infrared photoimmunotherapy (NIR-PIT) is an emerging treatment that is currently being investigated under a world-wide Phase III clinical trial and has been conditionally approved for the treatment of unresectable and/or recurrent HNSCC in Japan since 2021. Disease contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Nanami L., Furusawa, Aki, Choyke, Peter L., Kobayashi, Hisataka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650558/
https://www.ncbi.nlm.nih.gov/pubmed/37958293
http://dx.doi.org/10.3390/cancers15215117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650558/
https://www.ncbi.nlm.nih.gov/pubmed/37958293
http://dx.doi.org/10.3390/cancers15215117

Ejemplares similares